首页 > 最新文献

Molecular Imaging and Radionuclide Therapy最新文献

英文 中文
A Rare Case of Triple Primary Malignant Neoplasms (RCC and Colon Cancer) Detected by 18F-FDG PET/CT 一例通过 18F-FDG PET/CT 检测出的罕见的三原发性恶性肿瘤(RCC 和结肠癌)病例
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-07-08 DOI: 10.4274/mirt.galenos.2024.61214
Petya Nikolova, Valeria Hadzhiyska, Yavor Gramatikov, Stefani Veneva, Georgi Gaydarov, Elena Raycheva, M. Ilcheva
{"title":"A Rare Case of Triple Primary Malignant Neoplasms (RCC and Colon Cancer) Detected by 18F-FDG PET/CT","authors":"Petya Nikolova, Valeria Hadzhiyska, Yavor Gramatikov, Stefani Veneva, Georgi Gaydarov, Elena Raycheva, M. Ilcheva","doi":"10.4274/mirt.galenos.2024.61214","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2024.61214","url":null,"abstract":"","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":" 7","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141668677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comprehensive Analysis of Volumetric 68Ga-PSMA PET/CT Parameters, Clinical and Histopathologic Features: Evaluation of the Predictive Role. 全面分析容积 68Ga-PSMA PET/CT 参数、临床和组织病理学特征:评估预测作用。
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-06-28 DOI: 10.4274/mirt.galenos.2024.56933
Gözde Mutevelizade, Yasemin Parlak, Ceren Sezgin Arıkbası, Gül Gümüşer, Elvan Sayit

Objectives: To evaluate the relationships between volumetric 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) parameters, Gleason score (GS), prostate-specific antigen (PSA) levels, histopathological data, and metastatic status in newly diagnosed prostate cancer (PCa) patients and to assess the predictive factors for progression despite treatment.

Methods: A total of 78 newly diagnosed patients with PCa who had 68Ga-PSMA PET/CT scans were included. Clinical parameters, histopathological data, and metastatic status were documented, and volumetric parameters of primary prostate lesions were measured. All obtained data were compared statistically.

Results: Primary prostate tumor maximum standardized uptake value (SUVmax) and GS were significantly related to serum PSA levels (p<0.05). PSA levels and SUVmax values were significantly higher in patients with lymph node metastases than in those without. GS was found to be significantly increased in metastatic patients. PSMA-derived tumor volume (PSMA-TV) and total lesion PSMA of the primary lesion had a significant relationship with PSA value, GS, and regional lymph node metastases. Receiver operating characteristic analysis, conducted in patients with metastatic and localized disease, identified the cutoff value for SUVmax as 10.85. According to the results of the logistic regression analysis, PSMA-TV was found to be a predictive factor for progression despite treatment.

Conclusion: 68Ga-PSMA PET/CT remains an invaluable imaging modality that should be considered first in PCa staging because of its superior compatibility with clinical and histopathologic data. The importance of this method goes beyond diagnostic accuracy; it also extends into the predictive domain, where the PSMA-TV value of primary prostate lesions is a potential predictor of treatment efficacy. This information is valuable for personalizing patient treatment, improving prognostic accuracy, and predicting clinical outcomes.

研究目的评估新诊断的前列腺癌(PCa)患者的容积68Ga-前列腺特异性膜抗原(PSMA)正电子发射断层扫描/计算机断层扫描(PET/CT)参数、格里森评分(GS)、前列腺特异性抗原(PSA)水平、组织病理学数据和转移状态之间的关系,并评估治疗后病情进展的预测因素:方法:共纳入 78 名接受过 68Ga-PSMA PET/CT 扫描的新诊断 PCa 患者。记录临床参数、组织病理学数据和转移状态,并测量原发性前列腺病变的体积参数。对所有获得的数据进行统计学比较:结果:原发性前列腺肿瘤的最大标准化摄取值(SUVmax)和GS与血清PSA水平有显著关系(有淋巴结转移的患者的pmax值明显高于无淋巴结转移的患者)。淋巴结转移患者的 GS 值明显升高。原发病灶的 PSMA 衍生肿瘤体积(PSMA-TV)和总病灶 PSMA 与 PSA 值、GS 和区域淋巴结转移有显著关系。对转移性和局部性疾病患者进行的接收器操作特征分析确定了 SUVmax 的临界值为 10.85。结论:68Ga-PSMA PET/CT 仍是一种宝贵的成像模式,由于其与临床和组织病理学数据的兼容性极佳,因此在 PCa 分期中应首先考虑使用这种模式。该方法的重要性不仅体现在诊断准确性上,还体现在预测性上,原发性前列腺病变的 PSMA-TV 值是治疗效果的潜在预测指标。这些信息对于患者的个性化治疗、提高预后准确性和预测临床结果都很有价值。
{"title":"A Comprehensive Analysis of Volumetric <sup>68</sup>Ga-PSMA PET/CT Parameters, Clinical and Histopathologic Features: Evaluation of the Predictive Role.","authors":"Gözde Mutevelizade, Yasemin Parlak, Ceren Sezgin Arıkbası, Gül Gümüşer, Elvan Sayit","doi":"10.4274/mirt.galenos.2024.56933","DOIUrl":"10.4274/mirt.galenos.2024.56933","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the relationships between volumetric <sup>68</sup>Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) parameters, Gleason score (GS), prostate-specific antigen (PSA) levels, histopathological data, and metastatic status in newly diagnosed prostate cancer (PCa) patients and to assess the predictive factors for progression despite treatment.</p><p><strong>Methods: </strong>A total of 78 newly diagnosed patients with PCa who had <sup>68</sup>Ga-PSMA PET/CT scans were included. Clinical parameters, histopathological data, and metastatic status were documented, and volumetric parameters of primary prostate lesions were measured. All obtained data were compared statistically.</p><p><strong>Results: </strong>Primary prostate tumor maximum standardized uptake value (SUV<sub>max</sub>) and GS were significantly related to serum PSA levels (p<0.05). PSA levels and SUV<sub>max</sub> values were significantly higher in patients with lymph node metastases than in those without. GS was found to be significantly increased in metastatic patients. PSMA-derived tumor volume (PSMA-TV) and total lesion PSMA of the primary lesion had a significant relationship with PSA value, GS, and regional lymph node metastases. Receiver operating characteristic analysis, conducted in patients with metastatic and localized disease, identified the cutoff value for SUV<sub>max</sub> as 10.85. According to the results of the logistic regression analysis, PSMA-TV was found to be a predictive factor for progression despite treatment.</p><p><strong>Conclusion: </strong><sup>68</sup>Ga-PSMA PET/CT remains an invaluable imaging modality that should be considered first in PCa staging because of its superior compatibility with clinical and histopathologic data. The importance of this method goes beyond diagnostic accuracy; it also extends into the predictive domain, where the PSMA-TV value of primary prostate lesions is a potential predictor of treatment efficacy. This information is valuable for personalizing patient treatment, improving prognostic accuracy, and predicting clinical outcomes.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"33 2","pages":"68-76"},"PeriodicalIF":0.9,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589271/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paget’s Disease Mimicking Prostate Cancer Metastasis with 68Ga-PSMA PET/CT 利用 68Ga-PSMA PET/CT 模拟前列腺癌转移的髓鞘病
IF 0.9 Q3 Medicine Pub Date : 2024-06-13 DOI: 10.4274/mirt.galenos.2024.03521
Melis Oflas, E. Isik, Z. Özkan, Duygu Has Şimşek, Y. Şanlı
{"title":"Paget’s Disease Mimicking Prostate Cancer Metastasis with 68Ga-PSMA PET/CT","authors":"Melis Oflas, E. Isik, Z. Özkan, Duygu Has Şimşek, Y. Şanlı","doi":"10.4274/mirt.galenos.2024.03521","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2024.03521","url":null,"abstract":"","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"55 2","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141347796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bone Marrow Necrosis with Underlying Skeletal Lymphoma Evaluated by 18F-FDG PET/CT and MRI 通过 18F-FDG PET/CT 和核磁共振成像评估骨髓坏死伴骨骼淋巴瘤的情况
IF 0.9 Q3 Medicine Pub Date : 2024-06-13 DOI: 10.4274/mirt.galenos.2024.70037
Le Song, Hui Li, Weifang Zhang
{"title":"Bone Marrow Necrosis with Underlying Skeletal Lymphoma Evaluated by 18F-FDG PET/CT and MRI","authors":"Le Song, Hui Li, Weifang Zhang","doi":"10.4274/mirt.galenos.2024.70037","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2024.70037","url":null,"abstract":"","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"48 10","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141349071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tc-99m-MDP Uptake in Extraosseous Metastases From Ovarian Papillary Serous Adenocarcinoma 卵巢乳头状浆液性腺癌骨外转移的 Tc-99m-MDP 摄取
IF 0.9 Q3 Medicine Pub Date : 2024-06-13 DOI: 10.4274/mirt.galenos.2024.72687
Komal Bishnoi, K. Agrawal, P. Patro, G. Parida
{"title":"Tc-99m-MDP Uptake in Extraosseous Metastases From Ovarian Papillary Serous Adenocarcinoma","authors":"Komal Bishnoi, K. Agrawal, P. Patro, G. Parida","doi":"10.4274/mirt.galenos.2024.72687","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2024.72687","url":null,"abstract":"","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"94 3","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141347720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinguishing Bronchial Carcinoid from Benign Bronchocele using 68Ga-DOTATOC PET/CT Imaging 利用 68Ga-DOTATOC PET/CT 成像技术区分支气管类癌和良性支气管瘤
IF 0.9 Q3 Medicine Pub Date : 2024-06-13 DOI: 10.4274/mirt.galenos.2024.50103
Akram Al-Ibraheem, Raghad Alhouwari, Baraa Alsyouf, A. Abdlkadir, Hussam Haddad
{"title":"Distinguishing Bronchial Carcinoid from Benign Bronchocele using 68Ga-DOTATOC PET/CT Imaging","authors":"Akram Al-Ibraheem, Raghad Alhouwari, Baraa Alsyouf, A. Abdlkadir, Hussam Haddad","doi":"10.4274/mirt.galenos.2024.50103","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2024.50103","url":null,"abstract":"","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"60 15","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141349378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple Bone Involvement in Low-grade Myofibroblastic Sarcoma Demonstrated on 18F-FDG PET/CT 18F-FDG PET/CT 显示低级别肌纤维母细胞肉瘤多处骨质受累
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-06-13 DOI: 10.4274/mirt.galenos.2024.14238
Hui Li, Xiaoyan Hou, Na Guo, Le Song, Weifang Zhang
{"title":"Multiple Bone Involvement in Low-grade Myofibroblastic Sarcoma Demonstrated on 18F-FDG PET/CT","authors":"Hui Li, Xiaoyan Hou, Na Guo, Le Song, Weifang Zhang","doi":"10.4274/mirt.galenos.2024.14238","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2024.14238","url":null,"abstract":"","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"4 9","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141349638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrathyroidal Parathyroid Adenoma 甲状旁腺内腺瘤
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-06-13 DOI: 10.4274/mirt.galenos.2024.66934
Sara Zouggari, Mohamed Aziz Bsiss, A. Matrane, Abdelouahed Marrat, Ibtissam Zrara Touiti
{"title":"Intrathyroidal Parathyroid Adenoma","authors":"Sara Zouggari, Mohamed Aziz Bsiss, A. Matrane, Abdelouahed Marrat, Ibtissam Zrara Touiti","doi":"10.4274/mirt.galenos.2024.66934","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2024.66934","url":null,"abstract":"","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"62 4","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141346800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Diffuse Infiltrative Hepatocellular Carcinoma with Marked Response to Sorafenib Treatment Evidenced by 18F-FDG PET/MRI 一例通过 18F-FDG PET/MRI 证实对索拉非尼治疗有明显反应的弥漫浸润性肝细胞癌病例
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-04-16 DOI: 10.4274/mirt.galenos.2024.36043
E. Özkan, Burak Demir, Diğdem Kuru Öz, Y. Ürün, N. O. Küçük
A 73-year-old woman with known diagnosis of chronic hepatitis B infection referred for 18 F-fluorodeoxyglucose positron emission tomography/ computed tomography ( 18 F-FDG PET/CT) and magnetic resonance imaging (MRI) after detection of a liver mass with 9 cm diameter in contrast enhanced CT. However, 18 F-FDG PET/CT and MRI revealed diffuse infiltrating hepatocellular carcinoma lesions other than previously defined mass. After 9 months of Sorafenib treatment serum alpha feto protein levels dropped from 60,500 ng/mL to 801 ng/mL. Later 18 F-FDG PET/MRI was performed for evaluation of response to treatment and revealed marked response to treatment
一名 73 岁的妇女已知诊断为慢性乙型肝炎感染,在对比增强 CT 中发现一个直径 9 厘米的肝脏肿块,随后转诊到医院进行 18 F-FDG 正电子发射/计算机断层扫描(18 F-FDG PET/CT)和磁共振成像(MRI)检查。然而,18 F-FDG PET/CT 和核磁共振成像显示,除了之前确定的肿块外,还有弥漫浸润性肝细胞癌病灶。索拉非尼治疗9个月后,血清甲胎蛋白水平从60,500纳克/毫升降至801纳克/毫升。随后进行了 18 F-FDG PET/MRI,以评估治疗反应,结果显示治疗反应明显
{"title":"A Case of Diffuse Infiltrative Hepatocellular Carcinoma with Marked Response to Sorafenib Treatment Evidenced by 18F-FDG PET/MRI","authors":"E. Özkan, Burak Demir, Diğdem Kuru Öz, Y. Ürün, N. O. Küçük","doi":"10.4274/mirt.galenos.2024.36043","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2024.36043","url":null,"abstract":"A 73-year-old woman with known diagnosis of chronic hepatitis B infection referred for 18 F-fluorodeoxyglucose positron emission tomography/ computed tomography ( 18 F-FDG PET/CT) and magnetic resonance imaging (MRI) after detection of a liver mass with 9 cm diameter in contrast enhanced CT. However, 18 F-FDG PET/CT and MRI revealed diffuse infiltrating hepatocellular carcinoma lesions other than previously defined mass. After 9 months of Sorafenib treatment serum alpha feto protein levels dropped from 60,500 ng/mL to 801 ng/mL. Later 18 F-FDG PET/MRI was performed for evaluation of response to treatment and revealed marked response to treatment","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"107 7","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140695161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Performance of FAPI PET/CT vs. 18F-FDG PET/CT in Evaluation of Liver Tumors: A Systematic Review and Meta-analysis FAPI PET/CT 与 18F-FDG PET/CT 在肝脏肿瘤评估中的诊断性能:系统回顾与元分析
IF 0.9 Q3 Medicine Pub Date : 2024-04-16 DOI: 10.4274/mirt.galenos.2024.99705
Parneet Singh, T. Singhal, G. Parida, Ashique Rahman, K. Agrawal
{"title":"Diagnostic Performance of FAPI PET/CT vs. 18F-FDG PET/CT in Evaluation of Liver Tumors: A Systematic Review and Meta-analysis","authors":"Parneet Singh, T. Singhal, G. Parida, Ashique Rahman, K. Agrawal","doi":"10.4274/mirt.galenos.2024.99705","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2024.99705","url":null,"abstract":"","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"25 47","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140697247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Molecular Imaging and Radionuclide Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1